Skip to main content

4 Result(s)

within B. Idowu Remove this filter

and

  1. No Access

    Article

    Neurofibromatosis presenting with a cherubism phenotype

    We report on a child who presented clinical manifestations of both neurofibromatosis type 1 (NF1) and cherubism. With genetic testing, we found a mutation in the NF-1 gene, confirming the neurocutaneous disord...

    C. I. van Capelle, P. H. G. Hogeman… in European Journal of Pediatrics (2007)

  2. Article

    Open Access

    Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway

    Chordomas are radio- and chemo-resistant tumours and metastasise in as many as 40% of patients. The aim of this study was to identify potential molecular targets for the treatment of chordoma. In view of the r...

    N Presneau, A Shalaby, B Idowu, P Gikas, S R Cannon, I Gout… in British Journal of Cancer (2009)

    Download PDF (2032 KB) View Article

  3. Article

    Open Access

    Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service

    While existing evidence suggests less severe clinical manifestations and lower mortality are associated with the Omicron variant as compared to the Delta variant. However, these studies fail to control for dif...

    N. Radhakrishnan, M. Liu, B. Idowu, A. Bansari, K. Rathi… in BMC Infectious Diseases (2023)

    Download PDF (1259 KB) View Article

  4. Article

    Open Access

    Correction: Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service

    N. Radhakrishnan, M. Liu, B. Idowu, A. Bansari, K. Rathi… in BMC Infectious Diseases (2023)

    Download PDF (657 KB) View Article